Toronto, May 4, 2026, 12:04 EDT
Xanadu Quantum Technologies shares fell about 59% in late Monday morning trading after a U.S. resale prospectus registered up to 293.7 million Class B subordinate voting shares for sale by existing holders, jolting one of Canada’s most watched new quantum-computing listings. The Nasdaq-listed stock traded at $14.78, down from a previous close of $36.12.
The drop matters because the filing landed weeks after Xanadu’s Nasdaq and Toronto Stock Exchange debut, and after early Canadian backers were sitting on unusually large paper gains. OMERS-affiliated entities are listed in the prospectus for 40.25 million shares, implying a position worth about $595 million at the latest Nasdaq quote, compared with roughly $1.45 billion at Friday’s close.
It also changes the tone around a deal that had become a rare Canadian venture-capital win. A post by Globe and Mail reporter Sean Silcoff summarizing the paper said OMERS Ventures, Golden Ventures, Georgian, Real Ventures and Radical Ventures were among Canadian backers with gains on paper, while OMERS CEO Blake Hutcheson called the size of the pension fund’s exposure “wacky.” LinkedIn
The company will not receive cash from the shareholder resales. The prospectus says proceeds go to the selling securityholders, except for cash from the exercise of a small number of Royal Bank of Canada warrants, and it warns that large sales, or the market’s belief that they may happen, could weigh on the stock.
Class B subordinate voting shares are Xanadu’s publicly traded stock. The filing also covers Class A multiple voting shares that can convert into Class B shares on a one-for-one basis, including shares held by insiders, legacy investors, PIPE investors and the former Crane Harbor sponsor.
Xanadu completed its business combination with Crane Harbor Acquisition Corp. on March 26 and started trading under the ticker XNDU on March 27. A SPAC, or special purpose acquisition company, is a blank-check company formed to merge with a private business; Xanadu’s transaction also included a US$275 million PIPE, a private investment in public equity.
The resale filing does not mean the named holders sold stock on Monday. The prospectus says many old Xanadu shareholders face market standoff provisions that restrict lending, pledging, selling or transferring shares for up to 180 days after the closing date, with separate restrictions applying to some other holders.
Still, investors reacted to supply. The filing lists Christian Weedbrook, Xanadu’s founder and chief executive, for 46.4 million registered shares, OMERS-affiliated entities for 40.25 million, Georgian-affiliated entities for 29.7 million and Bessemer-affiliated entities for 22.9 million.
The pullback cuts against a still-bullish analyst case for photonic quantum computing, which uses light particles rather than other qubit systems to process information. Northland Capital Markets analyst Nehal Chokshi wrote last month that “photonic based quantum computers are best positioned” to reach broad quantum advantage, and initiated Xanadu with an Outperform rating and a $43 price target. Investing
Competition is intensifying. Northland also named IonQ as a top pick and was more cautious on D-Wave, while other quantum companies have used public markets and SPAC structures to fund long development cycles before broad commercial use.
The risk is that valuation keeps running ahead of revenue. Xanadu reported US$4.6 million of revenue and a US$70.7 million net loss for 2025, and said its near-term revenue reflects a pre-commercial state focused on longer-term utility-scale quantum computers.
But the downside scenario is not the only one. If holders remain locked up, the company shows technical progress and investors treat Monday’s move as a mechanical supply scare rather than a change in the business, the stock could stabilize; if registered shares keep pressing on the market while losses remain heavy, the reset could deepen.
Xanadu said it will release first-quarter results on May 14 after markets close, giving investors their next formal update since the public listing. For now, Monday’s selloff has turned the story from a Canadian quantum windfall into a test of how much public-market buyers will pay for a business still trying to turn deep science into durable revenue.
